Proton Pump Inhibitor Empirical Treatment in Management of Outpatients with Gastroesophageal Reflux Disease.

Trial Identifier: D1844R00002
Sponsor: AstraZeneca
NCTID:: NCT02606851
Start Date: December 2015
Primary Completion Date: December 2016
Study Completion Date: December 2016
Condition: Digestive & Intestinal - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
China Beijing, China
China Benijin, China
China Changchun, China
China Chongqing, China
China Guangzhou, China
China Hangzhou, China
China Nanjing, China
China Shanghai, China
China Tianjin, China
China Xining, China